- Lobbying
- Lobbying by The Conafay Group on behalf of Antibiotics Working Group
Lobbying Relationship
Bills mentioned
H.R.6: 21st Century Cures Act
Sponsor: Fred Upton (R-Mich.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Emily Wheeler | Intern, Rep. DeFazio |
Darin Gardner | Legislative Correspondent Senator Tim Hutchinson; Research Assistant Senate HELP Committee; Chief of Staff Congresswoman Kay Granger |
Joshua Narrow | Intern for Senator Casey |
Bryan Shuy | Chief of Staff Rep. Harris; Asst. to Rep. Harris, House Cmte on Approps; Dep. Asst. Sec and Chief of Staff HHS/Asst. Secretary for Preparedness and Response (ASPR) |
Stehen Conafay | n/a |
Melissa Dupree | n/a |
William Franco | n/a |
Stephen Conafay | n/a |
Patrick Plues | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Q1 Report
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Centers For Medicare and Medicaid Services (CMS)
Executive Office of the President (EOP)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Centers For Medicare and Medicaid Services (CMS)
Executive Office of the President (EOP)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Centers For Medicare and Medicaid Services (CMS)
Executive Office of the President (EOP)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Centers For Medicare and Medicaid Services (CMS)
Executive Office of the President (EOP)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Centers For Medicare and Medicaid Services (CMS)
Executive Office of the President (EOP)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Centers For Medicare and Medicaid Services (CMS)
Executive Office of the President (EOP)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Centers For Medicare and Medicaid Services (CMS)
Executive Office of the President (EOP)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Centers For Medicare and Medicaid Services (CMS)
Executive Office of the President (EOP)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Centers For Medicare and Medicaid Services (CMS)
Executive Office of the President (EOP)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Centers For Medicare and Medicaid Services (CMS)
Executive Office of the President (EOP)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Centers For Medicare and Medicaid Services (CMS)
Executive Office of the President (EOP)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Centers For Medicare and Medicaid Services (CMS)
Executive Office of the President (EOP)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Centers For Medicare and Medicaid Services (CMS)
Executive Office of the President (EOP)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Centers For Medicare and Medicaid Services (CMS)
Executive Office of the President (EOP)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Centers For Medicare and Medicaid Services (CMS)
Executive Office of the President (EOP)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Centers For Medicare and Medicaid Services (CMS)
Executive Office of the President (EOP)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Centers For Medicare and Medicaid Services (CMS)
Executive Office of the President (EOP)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Centers For Medicare and Medicaid Services (CMS)
Executive Office of the President (EOP)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Centers For Medicare and Medicaid Services (CMS)
Executive Office of the President (EOP)
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Centers For Medicare and Medicaid Services (CMS)
Executive Office of the President (EOP)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Centers For Medicare and Medicaid Services (CMS)
Executive Office of the President (EOP)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Health & Human Services - Dept of (HHS)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q4 Report
Q3 Report
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q1 Report
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate,
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate,
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
U.S. Senate,
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate,
Type of Issue
Registration
Issue(s) they said they’d lobby about: Improving the enviroment for antibiotic drug development.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate